site stats

Pascal apellis

WebFounders Cedric Francois, Pascal Deschatelets Operating Status Active Last Funding Type Post-IPO Equity Legal Name Apellis Pharmaceuticals, Inc. Stock Symbol NASDAQ:APLS Company Type For Profit Contact Email [email protected] Phone Number 502-241-4114 WebJoining Apellis Pharmaceuticals - Employee Onboarding. The prevailing opinion from Comparably users in Lexington, KY about their company is that it was very prepared on their first day. ... Dr. Pascal Deschatelets, PhD. Co-founded Apellis Pharmaceuticals, Inc. in November 2009 and has been its Chief Operating... Ahmad Sadr VP - Technical ...

APLS Apellis Pharmaceuticals Inc. Stock Overview (U.S.: …

WebApr 12, 2024 · Apellis Pharmaceuticals, Inc. ( NASDAQ:APLS – Get Rating) insider Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock in a transaction on Monday, April 10th. The shares... WebFeb 22, 2024 · Deschatelets Pascal Apellis Pharmaceuticals, Inc. [ APLS ] Director 10% Owner X Officer (give title below) Other (specify below) Chief Scientific Officer C/O … ladybridge club house cheadle hulme https://pmellison.com

investors.apellis.com

WebOur Products - Apellis Our Products Please see full Prescribing Information, including Boxed WARNING and Medication Guide. Patients and healthcare providers in the United States can learn more at: EMPAVELI.COM … WebPascal DESCHATELETS, Chief Scientific Officer Cited by 1,262 of Apellis Pharmaceuticals, Westwood Read 33 publications Contact Pascal DESCHATELETS WebAt Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. We Advance Courageous Science Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade. property management lima ohio

investors.apellis.com

Category:Pascal Deschatelets - Biography

Tags:Pascal apellis

Pascal apellis

APLS Stock Price Apellis Pharmaceuticals Inc. Stock Quote (U.S ...

WebMar 23, 2024 · As Chief Executive Officer of Apellis Pharmaceuticals, Inc, Cedric Francois has a total base salary of $618,769 . Cedric Francois received compensation valued at about $9,275,425 in 2024 after ... WebApr 12, 2024 · On Wednesday, March 8th, Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock. The shares were sold at an average price of $63.79, for a total value of $765,480.00.

Pascal apellis

Did you know?

WebApr 11, 2024 · Pascal Deschatelets owns over 18,500 units of Apellis Pharmaceuticals Inc stock worth over $68,124,345 and over the last 4 years he sold APLS stock worth over … WebDeschatelets Pascal (Last) (First) (Middle) C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR (Street) WALTHAM MA 02451 (City) (State) (Zip) 2. …

WebApr 12, 2024 · Apellis Pharmaceuticals, Inc. ( NASDAQ:APLS – Get Rating) insider Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock in a transaction on … WebApellis Pharmaceuticals Inc (APLS) Stock Price Today, News, Quotes, FAQs and Fundamentals DIA 0.13% SPY 0.28% QQQ 0.54% Trending ACH.X 2.87% BUD 2.50% TGTX 22.42% IOVA 8.94% SAVA 5.55% ELOX 58.33% MU 8.14% AMP.X 1.63% PXD 6.12% EBIX 16.32% More Advertisement 3rd Party Ad. Not an offer or recommendation …

WebPascal Deschatelets is Chief Scientific Officer/Co-Founder at Apellis Pharmaceuticals Inc. See Pascal Deschatelets's compensation, career history, education, & memberships. WebApr 14, 2024 · On Wednesday, February 8th, Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock. The shares were sold at an average price of $54.45, for …

WebApr 7, 2024 · As of April 7, 2024, the average one-year price target for Apellis Pharmaceuticals is $87.04. The forecasts range from a low of $51.51 to a high of …

WebAPLS: Get the latest Apellis Pharmaceuticals stock price and detailed information including APLS news, historical charts and realtime prices. ... Deschatelets Pascal: 03/07/2024 63.79 Sell No ... ladybridge pharmacy bl3 4pzWebCo-Founder & Chief Scientific Officer Apellis Pharmaceuticals May 2024 - Present3 years Waltham, Massachusetts, United States Languages English Native or bilingual … ladybridge cricket clubWebPascal Deschatelets is an entrepreneur who founded Apellis Pharmaceuticals, Inc., Potentia Pharmaceuticals, Inc., Revon Systems, Inc. and Syntetica Fine Chemicals. … ladybridge high school websiteWebLukas Scheibler, PhD. Chief Research Officer. Lukas joined Apellis in April 2024 as executive vice president for research and translational medicine. In this role, he is responsible for creating and managing all preclinical research projects and advancing them into clinical development to establish proof of concept. Lukas is an R&D professional ... property management locksmith leon countyWebFrom Humble Origins In The Bluegrass State. The Apellis story begins nearly 20 years ago with a company called Potentia Pharmaceuticals, a venture formed by two roommates in … property management lockboxWebAt Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face. We Advance … property management madison alWebFounders Cedric Francois, Pascal Deschatelets. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Apellis Pharmaceuticals, Inc. Stock Symbol … ladybridge football club bolton